Journals / Journal of critical and intensive care (Online) / 2020 / Cilt: 11 - Sayı: 1
Convalescent Plasma and Mesenchymal Stem Cell Therapy
- Pages
- 41–42
- DOI
- —
Abstract
Since there are no currently accepted therapies for corona virus disease 2019 (COVID-2019), worldwidesearch for treatment options are ongoing. Convalescent plasma therapy and mesenchymal stem cell therapyare considered as two of potential options. Convalescent plasma therapy may be recommended early duringthe course of severe or rapidly progressive illness, despite paucity of evidence. However, mesenchymal stem celltherapy for COVID-19 should only be considered in the context of a trial.